Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

192
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
192
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

291
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
291
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

153
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
153
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

358
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
358
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

358
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
358
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

215
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Rezafungin and catheter-related candidemia: a new player in a high-stakes game.

Le infezioni in medicina·2026
Same author

Eravacycline in sepsis complicated by <i>Clostridioides difficile</i> infection: a brief case series.

Journal of chemotherapy (Florence, Italy)·2026
Same author

[Gender bias and artificial intelligence in cardiology: evidence, clinical implications, and future perspectives].

Giornale italiano di cardiologia (2006)·2026
Same author

Multiple-site venous thromboembolism in acute toxoplasmosis: report of two cases.

The new microbiologica·2026
Same author

Enterovirus respiratory infection in adults: an overlooked clinical burden emerging in the post-pandemic era.

Le infezioni in medicina·2026
Same author

[Transgender individuals and cardiovascular risk: what should the cardiologist know].

Giornale italiano di cardiologia (2006)·2026
Same journal

Effectiveness and Safety Profile of BIC/TAF/FTC in People living with HIV Switched from Other Antiretroviral Regimens: A Real-Life Retrospective Cohort Analysis.

Le infezioni in medicina·2026
Same journal

Insights into parvovirus B19 clinical and virological dynamics among blood donors.

Le infezioni in medicina·2026
Same journal

When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship.

Le infezioni in medicina·2026
Same journal

Fragility of Immunisation and Water Systems in Gaza: Infectious Disease Risks in a Conflict-Affected Setting.

Le infezioni in medicina·2026
Same journal

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.7K

Halfway between Cure and Care: Suppressive Therapy in Inoperable Infective Endocarditis.

Sergio Venturini1, Ingrid Reffo2, Laura Munaretto3

  • 1Department of Infectious Diseases, ASFO "Santa Maria degli Angeli" Hospital of Pordenone, Pordenone, Italy.

Le Infezioni in Medicina
|December 12, 2025
PubMed
Summary
This summary is machine-generated.

Long-term suppressive antimicrobial therapy (SAT) is a viable option for elderly patients with infective endocarditis (IE) who cannot undergo surgery. This approach showed low mortality and relapse rates, with manageable adverse events, highlighting the importance of careful patient selection and monitoring.

Keywords:
infective endocarditismultidisciplinary endocarditis teamprosthetic valve endocarditissuppressive antimicrobial therapy

More Related Videos

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

12.0K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

497

Related Experiment Videos

Last Updated: Jan 7, 2026

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.7K
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

12.0K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

497

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Infective endocarditis (IE) presents a significant mortality risk, particularly in elderly patients with comorbidities where surgery is often contraindicated.
  • Long-term suppressive antimicrobial therapy (SAT) is an emerging strategy to manage IE in high-risk surgical candidates, aiming to reduce relapse and maintain stability.

Purpose of the Study:

  • To evaluate the efficacy and safety of long-term suppressive antimicrobial therapy (SAT) in adult patients with infective endocarditis (IE) ineligible for curative surgery.
  • To assess outcomes including mortality, infection relapse, and adverse drug events (ADEs) associated with SAT in this patient population.

Main Methods:

  • A retrospective, single-center observational study included 34 adult IE patients managed with SAT after initial intravenous treatment from January 2020 to July 2024.
  • Patients were selected by a Multidisciplinary Endocarditis Team (MET) due to surgical ineligibility or prior surgical failure.
  • Primary outcomes were all-cause mortality and infection relapse; secondary outcomes included SAT characteristics and ADEs.

Main Results:

  • The median patient age was 77 years, with a median Charlson Comorbidity Index of 6. Prosthetic valve endocarditis (PVE) was common (70.6%).
  • Staphylococci, streptococci, and Enterococcus faecalis were the most frequent pathogens.
  • All-cause mortality was 14.7% (5/34), and the relapse rate was 11.8% (4/34), with no relapses after SAT discontinuation by MET decision. ADEs occurred in 17.6% (6/34) without treatment suspension.

Conclusions:

  • Long-term suppressive antimicrobial therapy (SAT) is a feasible strategy for non-operable infective endocarditis (IE) patients.
  • Careful patient selection and rigorous follow-up are essential to balance the risks of recurrence, drug events, and prolonged antibiotic exposure.